Loading cancer entity…
Loading cancer entity…
Clinical trials
17 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05797246 | Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) | active not recruiting | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Sep 16, 2026 | clinicaltrials |
| NCT05688488 | Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords | recruiting | Phase 1 / Phase 2 | 100 | Eye & ENT Hospital of Fudan UniversityOTHER | 1 | May 6, 2023 | clinicaltrials |
| NCT00592319 | Celebrex (Celecoxib) Treatment of Laryngeal Papilloma | terminated | Phase 2 | 10 | Boston UniversityOTHER | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00038714 | A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis |
Data updated 14 days agoSource updated Sep 16, 2026source: clinicaltrials
| completed |
| Phase 2 |
| 27 |
| Nventa Biopharmaceuticals CorporationINDUSTRY |
| 1 |
| Jun 27, 2007 |
| clinicaltrials |